|
Nicholas L. Teti, Jr. was appointed to Chairman and Chief Executive Officer (CEO) in June 2006. Mr. Teti has more than 30 years of industry experience. Prior to joining Isolagen, he served as Chairman of the Board and CEO of Inamed Corporation, a position he assumed in July 2001. Previously, Mr. Teti spent 25 years at DuPont and DuPont Merck where he held a number of senior management positions including President and CEO of DuPont Pharmaceuticals. Mr. Teti is an industry leader who brings strong experience to Isolagen including an understanding of the regulatory, clinical development and marketing process for products in the biotechnology and pharmaceuticals industry. Mr. Teti earned an MBA in healthcare administration and a BA in economics from St. Joseph’s University in Philadelphia, PA.
| 